Selected Lab Publications


  1. Rodriguez FJ. N for nucleus in neurofibromin: new role for an old tumor suppressor? J Neurochem. 2016 Jan;136(1):11-2.
  2. Kahlert UD, Cheng M, Koch K, Marchionni L, Fan X, Raabe EH, Maciaczyk J, Glunde K, Eberhart CG. Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells. Int J Cancer. 2016 Mar 1;138(5):1246-55.
  3. AlWadani S, Suarez MJ, Kass JJ, MacQuaid E, Edward DP, Alkatan H, Eberhart C. Subepidermal Calcified Nodules of the Eyelid Differ in Children and Adults. Ophthal Plast Reconstr Surg. 2016 Jul 29. [Epub ahead of print]
  4. Bell WR, Singh K, Rajan Kd A, Eberhart CG. Expression of p16 and p53 in Intraepithelial Periocular Sebaceous Carcinoma. Ocul Oncol Pathol. 2015 Dec;2(2):71-5. doi: 10.1159/000439308. Epub 2015 Sep 18.
  5. Kaur H, Ali SZ, Huey L, Hütt-Cabezas M, Taylor I, Mao XG, Weingart M, Chu Q, Rodriguez FJ, Eberhart CG, Raabe EH. The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma. Cancer Lett. 2016 Jul 10;377(1):55-64. doi: 10.1016/j.canlet.2016.04.020. Epub 2016 Apr 18.
  6. Eberhart C. Multiple cilia suppress tumour formation. Nat Cell Biol. 2016 Apr;18(4):368-9. doi: 10.1038/ncb3331.
  7. Hanaford AR, Archer TC, Price A, Kahlert UD, Maciaczyk J, Nikkhah G, Kim JW, Ehrenberger T, Clemons PA, Dančík V, Seashore-Ludlow B, Viswanathan V, Stewart ML, Rees MG, Shamji A, Schreiber S, Fraenkel E, Pomeroy SL, Mesirov JP, Tamayo P, Eberhart CG, Raabe EH. DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets. Clin Cancer Res. 2016 Aug 1;22(15):3903-14. doi: 10.1158/1078-0432.CCR-15-3011. Epub 2016 Mar 24.
  8. Mahale A, Alkatan H, Alwadani S, Othman M, Suarez MJ, Price A, Al-Hussain H, Jastaneiah S, Yu W, Maktabi A, Deepak EP, Eberhart CG, Asnaghi L. Altered gene expression in conjunctival squamous cell carcinoma. Mod Pathol. 2016 May;29(5):452-60. doi: 10.1038/modpathol.2016.41. Epub 2016 Feb 26.
  9. Rodriguez FJ, Vizcaino MA, Blakeley J, Heaphy CM. Frequent alternative lengthening of    telomeres and ATRX loss in adult NF1-associated diffuse and high-grade astrocytomas. Acta Neuropathol. 2016 Sep 20.
  10. Rodriguez FJ, Vizcaino MA, Lin MT. Recent Advances on the Molecular Pathology of Glial Neoplasms in Children and Adults. J Mol Diagn. 2016 Sep;18(5):620-34. doi: 10.1016/j.jmoldx.2016.05.005.
  11. Suarez MJ, Rivera-Michlig R, Dubovy S, Rodriguez FJ. Clinicopathological Features of Ophthalmic Neoplasms Arising in the Setting of Xeroderma Pigmentosum. Ocul Oncol Pathol. 2015 Dec;2(2):112-21. doi: 10.1159/000441527. Epub 2015 Nov 12.
  12. Vizcaíno MA, Bishop J, Sharma R, Refaey K, Quiñones-Hinojosa A, Rodriguez FJ. Intracranial solitary fibrous tumor/ hemangiopericytoma with osteoclast-like multinucleated giant cells: comparison with giant cell-rich solitary fibrous tumor. Clin Neuropathol. 2016 Jul-Aug;35(4):171-7. doi: 10.5414/NP300933.
  13. Asnaghi L, Tripathy A, Yang Q, Kaur H, Hanaford A, Yu W, Eberhart CG. Targeting Notch signaling as a novel therapy for retinoblastoma. Oncotarget. 2016 Sep 20. doi: 10.18632/oncotarget.12142. [Epub ahead of print]


  1. Lim KJ, Brandt WD, Heth JA, Muraszko KM, Fan X, Bar EE, Eberhart CG. Lateral inhibition of Notch signaling in neoplastic cells. Oncotarget. 2015 Jan 30;6(3):1666-77.
  2. Brandt WD, Schreck KC, Bar EE, Taylor I, Marchionni L, Raabe E, Eberhart CG, Rodriguez FJ. Notch signaling activation in pediatric low-grade astrocytoma. J Neuropathol Exp Neurol. 2015 Feb;74(2):121-31.
  3. Kaur H, Hütt-Cabezas M, Weingart MF, Xu J, Kuwahara Y, Erdreich-Epstein A, Weissman BE, Eberhart CG, Raabe EH. The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity. J Neuropathol Exp Neurol. 2015 Feb;74(2):177-85.
  4. Weingart MF, Roth JJ, Hutt-Cabezas M, Busse TM, Kaur H, Price A, Maynard R, Rubens J, Taylor I, Mao XG, Xu J, Kuwahara Y, Allen SJ, Erdreich-Epstein A, Weissman BE, Orr BA, Eberhart CG, Biegel JA, Raabe EH. Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target. Oncotarget. 2015 Feb 20;6(5):3165-77.
  5. Taylor IC, Hütt-Cabezas M, Brandt WD, Kambhampati M, Nazarian J, Chang HT, Warren KE, Eberhart CG, Raabe EH. Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain Inhibition. J Neuropathol Exp Neurol. 2015 Aug;74(8):778-90.
  6. Vizcaíno MA, Shah S, Eberhart CG, Rodriguez FJ. Clinicopathologic implications of NF1 gene alterations in diffuse gliomas. Hum Pathol. 2015 Sep;46(9):1323-30. doi: 10.1016/j.humpath.2015.05.014
  7. Kahlert UD, Suwala AK, Koch K, Natsumeda M, Orr BA, Hayashi M, Maciaczyk J, Eberhart CG. Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells. J Neuropathol Exp Neurol. 2015 Sep;74(9):889-900.
  8. Asnaghi L, Gezgin G, Tripathy A, Handa JT, Merbs SL, van der Velden PA, Jager MJ, Harbour JW, Eberhart CG. EMT-associated factors promote invasive properties of uveal melanoma cells. Mol Vis. 2015 Aug 25;21:919-29.
  9. Natsumeda M, Maitani K, Liu Y, Miyahara H, Kaur H, Chu Q, Zhang H, Kahlert U, Eberhart CG. Targeting Notch Signaling and Autophagy Increases Cytotoxicity in Glioblastoma Neurospheres. Brain Pathol. 2015 Nov 27.
  10. Ho CY, Mosier S, Safneck J, Salomao DR, Miller NR, Eberhart CG, Gocke CD, Batista DA, Rodriguez FJ. Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningioma. Brain Pathol. 2015 Mar;25(2):193-201.
  11. Nauen D, Haley L, Lin MT, Perry A, Giannini C, Burger PC, Rodriguez FJ. Molecular Analysis of Pediatric Oligodendrogliomas Highlights Genetic Differences with Adult Counterparts and Other Pediatric Gliomas. Brain Pathol. 2015 Jul 23.
  12. Ho CY, Mobley BC, Gordish-Dressman H, VandenBussche CJ, Mason GE, Bornhorst M, Esbenshade AJ, Tehrani M, Orr BA, LaFrance DR, Devaney JM, Meltzer BW, Hofherr SE, Burger PC, Packer RJ, Rodriguez FJ. A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation. Acta Neuropathol. 2015 Oct;130(4):575-85.
  13. Rodriguez, FJ; Schniederjan, MJ; Nicolaides, T; Tihan, T; Burger, PC; Perry, A. High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN). Acta Neuropathol., 2015 vol. 129(4) pp. 609-10.
  14. Grasso CS, Tang Y, Truffaux N, Berlow NE, Liu L, Debily MA, Quist MJ, Davis LE, Huang EC, Woo PJ, Ponnuswami A, Chen S, Johung TB, Sun W, Kogiso M, Du Y, Qi L, Huang Y, Hütt-Cabezas M, Warren KE, Le Dret L, Meltzer PS, Mao H, Quezado M, van Vuurden DG, Abraham J, Fouladi M, Svalina MN, Wang N, Hawkins C, Nazarian J, Alonso MM, Raabe EH, Hulleman E, Spellman PT, Li XN, Keller C, Pal R, Grill J, Monje M. Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med. 2015 Jun;21(6):555-9.


  1. AlWadani S, Robinson S, Myers R, Akpek EK, Eberhart CG. No increase in IgG4-positive plasma cells in limbal Rosai-Dorfman disease. Cornea. 2014 Aug;33(8):844-7.
  2. Ahsan S, Raabe EH, Haffner MC, Vaghasia A, Warren KE, Quezado M, Ballester LY, Nazarian J, Eberhart CG, Rodriguez FJ. Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma. Acta Neuropathol Commun. 2014 Jun 3;2:59.
  3. Orr BA, Eberhart CG. Molecular pathways: not a simple tube–the many functions of blood vessels. Clin Cancer Res. 2015 Jan 1;21(1):18-23.
  4. Rajaii F, Asnaghi L, Enke R, Merbs SL, Handa JT, Eberhart CG. The demethylating agent 5-Aza reduces the growth, invasiveness, and clonogenicity of uveal and cutaneous melanoma. Invest Ophthalmol Vis Sci. 2014 Aug 21;55(10):6178-86.
  5. Asnaghi L, Lin MH, Lim KS, Lim KJ, Tripathy A, Wendeborn M, Merbs SL, Handa JT, Sodhi A, Bar EE, Eberhart CG. Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation. PLoS One. 2014 Aug 28;9(8):e105372.
  6. Asnaghi L, Alkatan H, Mahale A, Othman M, Alwadani S, Al-Hussain H, Jastaneiah S, Yu W, Maktabi A, Edward DP, Eberhart CG. Identification of multiple DNA copy number alterations including frequent 8p11.22 amplification in conjunctival squamous cell carcinoma. Invest Ophthalmol Vis Sci. 2014 Dec 9;55(12):8604-13.
  7. Rodriguez FJ, Raabe EH. mTOR: a new therapeutic target for pediatric low-grade glioma? CNS Oncol. 2014 Mar;3(2):89-91.
  8. Cameron JD, Rodriguez FJ, Rushing E, Horkayne-Szakaly I, Eberhart C. An 80-year experience with optic nerve glioma cases at the Armed Forces Institute of Pathology: evolution from museum to molecular evaluation suggests possibe interventions in the cellular senescence and microglial pathways (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2014;112:11-25.
  9. Ding D, Lim Ks, Eberhart CG.  Arsenic trioxide inhibits hedgehog, notch and stem cell properties in glioblastoma neurospheres.  Acta Neuropathol Commun 2014;31;2(1):31.
  10. Rajan A, Burris C, Iliff N, Grant M, Eshleman JR, Eberhart CG.  DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma.  Am J Ophthalmol 2014;157:640-7.
  11. Kahlert UD, Suwala AK, Raabe EH, Siebzehnrubi FA, Suarez MJ, Orr BA, Bar EE, Maciaczyk J, Eberhart CG.  ZEB1 promotes invasion in human fetal neural stem cells and hypoxic glioma neurospheres.  Brain Pathol 2014 Dec 17.
  12. Saratsis AM, Kambhampati M, Snyder K, Yadavilli S, Devaney JM, Harmon B, Hall J, Raabe EH, An P, Weingart M, Rood BR, Magge SN, MacDonald TJ, Packer RJ, Nazarian J. Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes. Acta Neuropathol. 2014;127(6):881-95. doi: 10.1007/s00401-013-1218-2. Epub 2013 Dec 3.


  1. Mao XG, Hütt-Cabezas M, Orr BA, Weingart M, Taylor I, Rajan AK, Odia Y, Kahlert U, Maciaczyk J, Nikkhah G, Eberhart CG, Raabe EH. LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program. Oncotarget. 2013 Jul;4(7):1050-64.
  2. Odia Y, Orr BA, Bell WR, Eberhart CG, Rodriguez FJ. . cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome. J Neurooncol. 2013 Nov;115(2):249-59.
  3. Heaphy CM, Schreck KC, Raabe E, Mao XG, An P, Chu Q, Poh W, Jiao Y, Rodriguez FJ, Odia Y, Meeker AK, Eberhart CG. A glioblastoma neurosphere line with alternative lengthening of telomeres. Acta Neuropathol. 2013 Oct;126(4):607-8.
  4. Lim KS, Lim KJ, Price AC, Orr BA, Eberhart CG, Bar EE. Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner. Oncogene. 2014 Aug 28;33(35):4433-41.
  5. Hütt-Cabezas M, Karajannis MA, Zagzag D, Shah S, Horkayne-Szakaly I, Rushing EJ, Cameron JD, Jain D, Eberhart CG, Raabe EH, Rodriguez FJ. Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target. Neuro Oncol. 2013 Dec;15(12):1604-14.
  6. Rajan Kd A, Burris C, Iliff N, Grant M, Eshleman JR, Eberhart CG. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma. Am J Ophthalmol. 2014 Mar;157(3):640-7.e1-2. doi: 10.1016/j.ajo.2013.12.002.
  7. Rajaii F, Ghafourian A, Eberhart CG. Intratarsal keratinous cyst – an emerging entity. Case Rep Ophthalmol. 2013 Oct 5;4(3):160-4.
  8. Codispoti KE, Mosier S, Ramsey R, Lin MT, Rodriguez FJ. Genetic and pathologic evolution of early secondary gliosarcoma. Brain Tumor Pathol. 2014 Jan;31(1):40-6. doi: 10.1007/s10014-012-0132-y.
  9. Nguyen DN, Heaphy CM, de Wilde RF, Orr BA, Odia Y, Eberhart CG, Meeker AK, Rodriguez FJ.  Molecular and Morphologic Correlates of the Alternative Lengthening of Telomeres Phenotype in High-Grade Astrocytomas.  Brain Pathol 2013;23(3):237-43.
  10. Chu Q, Orr BA, Semenkow S, Bar EE, Eberhart CG.  Prolonged Inhibition of Glioblastoma Xenograft Initiation and Clonogenic Growth following In Vivo Notch Blockade. Clin Cancer Res 2013;19(12):3224-33.
  11. Asnaghi L, Handa JT, Merbs SL, Harbour JW, Eberhart CG.  A role for Jag2 in promoting uveal melanoma dissemination and growth. Invest Ophthalmol Vis Sci 2013;54(1):295-306.
  12. Ballester LY, Wang Z, Shandilya S, Miettinen M, Burger PC, Eberhart CG, Rodriguez FJ, Raabe E, Nazarian J, Warren K, Quezado MM. Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas. Am J Surg Pathol. 2013 Sep;37(9):1357-64. doi: 10.1097/PAS.0b013e318294e817.


  1. Orr BA, Eberhart CG. Nature versus nurture in glioblastoma: microenvironment and genetics can both drive mesenchymal transcriptional signature. Am J Pathol. 2012 May;180(5):1768-71.
  2. Lim KJ, Rajan K, Eberhart CG. Effects of Zeng Sheng Ping/ACAPHA on malignant brain tumor growth and Notch signaling. Anticancer Res. 2012 Jul;32(7):2689-96.
  3. Orr BA, Haffner MC, Nelson WG, Yegnasubramanian S, Eberhart CG. Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PLoS One. 2012;7(7):e41036
  4. Rodriguez FJ, Ligon AH, Horkayne-Szakaly I, Rushing EJ, Ligon KL, Vena N, Garcia DI, Cameron JD, Eberhart CG. BRAF duplications and MAPK pathway activation are frequent in gliomas of the optic nerve proper. J Neuropathol Exp Neurol. 2012 Sep;71(9):789-94.
  5. Nguyen DN, Heaphy CM, de Wilde RF, Orr BA, Odia Y, Eberhart CG, Meeker AK, Rodriguez FJ. Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas. Brain Pathol. 2013 May;23(3):237-43.
  6. Raabe EH, Eberhart CG. Methylome alterations “mark” new therapeutic opportunities in glioblastoma. Cancer Cell. 2012 Oct 16;22(4):417-8.
  7. Rodriguez FJ, Lim KS, Bowers D, Eberhart CG. Pathological and molecular advances in pediatric low-grade astrocytoma. Annu Rev Pathol. 2013 Jan 24;8:361-79.
  8. Ho CY, Bar E, Giannini C, Marchionni L, Karajannis MA, Zagzag D, Gutmann DH, Eberhart CG, Rodriguez FJ. MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2. Neuro Oncol. 2013 Jan;15(1):69-82.
  9. Lin A, Rodriguez FJ, Karajannis MA, Williams SC, Legault G, Zagzag D, Burger PC, Allen JC, Eberhart CG, Bar EE. BRAF Alterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549: BRAF Fusion Variants. J Neuropathol Exp Neurol 2012;71:66-72.
  10. Rodriguez FJ, Orr BA, Ligon KL, Eberhart CG.  Neoplastic cells are a rare component in human glioblastoma microvasculature.  Oncotarget 2012;3:98-106.
  11. Asnaghi L, Ebrahimi KB, Schreck KC, Bar EE, Coonfield ML, Bell WR, Handa J, Merbs SL, Harbour JW, Eberhart CG.  Notch signaling promotes growth and invasion in uveal melanoma. Clin Cancer Res 2012;18(3):654-65.
  12. Rodriguez FJ, Perry A, Rosenblum MK, Krawitz S, Cohen KJ, Lin D, Mosier S, Lin MT, Eberhart CG, Burger PC. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol 2012;124(5):627-41.


  1. Pierfelice TJ, Schreck KC, Dang L, Asnaghi L, Gaiano N, Eberhart CG. Notch3 activation promotes invasive glioma formation in a tissue site-specific manner. Cancer Res. 2011 Feb 1;71(3):1115-25.
  2. Raabe EH, Lim KS, Kim JM, Meeker A, Mao XG, Nikkhah G, Maciaczyk J, Kahlert U, Jain D, Bar E, Cohen KJ, Eberhart CG. BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model. Clin Cancer Res. 2011 Jun 1;17(11):3590-9.
  3. Orr BA, Bai H, Odia Y, Jain D, Anders RA, Eberhart CG. Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth. J Neuropathol Exp Neurol. 2011 Jul;70(7):568-77.
  4. Karafin M, Jallo GI, Ayars M, Eberhart CG, Rodriguez FJ. Rosette forming glioneuronal tumor in association with Noonan syndrome: pathobiological implications. Clin Neuropathol. 2011 Nov-Dec;30(6):297-300.
  5. Eberhart CG.  Molecular diagnostics in embryonal brain tumors.  Brain Pathol 2011:21(1):96-104.
  6. Lim KJ, Bisht S, Bar EE, Maitra A, Eberhart CG.  A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors.  Cancer Biol Ther 2011
  7. Bar EE. Glioblastoma, cancer stem cells and hypoxia. Brain Pathol. 2011 Mar;21(2):119-29.


  1. Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG. NOTCH Pathway Blockade Depletes CD133-Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts. Stem Cells. 2010, 28(1):5-16.
  2. Bar EE, Lin A, Mahairaki V, Matsui W, and Eberhart CG. Hypoxia Increases the Expression of Stem-Cell Markers and Promotes Clonogenicity in Glioblastoma Neurospheres. Am J Pathol 2010, 177(3):1491-502.
  3. Schreck KC, Taylor P, Marchionni L, Gopalakrishnan V, Bar EE, Gaiano N, Eberhart CG.  The notch target hes1 directly modulates gli1 expression and hedgehog signaling:  a potential mechanism of therapeutic resistance.  Clin Cancer Res 2010:16(24):6060-70.


  1. Bar EE, Lin A, Tihan T, Burger PC, Eberhart CG. Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. J Neuropathol Exp Neurol. 2008, 67:878-87.
  2. Fan X, Eberhart CG. Medulloblastoma stem cells. J Clin Oncol. 2008, 26:2821-7.


  1. E Bar, A Chaudhry, CG Eberhart. Hedgehog Signaling Promotes Medulloblastoma Survival via Bcl2. American Journal of Pathology 2007, 170:347-55.
  2. Bar EE, Chaudhry A, Lin A, Fan X, Schreck K, Matsui W, Vescovi AL, Piccirillo S, Dimeco F, Olivi A, Eberhart CG. Cyclopamine-Mediated Hedgehog Pathway Inhibition Depletes Stem-Like Cancer Cells in Glioblastoma. Stem Cells. 2007, 25:2524-33.


  1. Dang L, Fan X, Chaudhry A, Wang M, Gaiano N, and CG Eberhart. Notch3 Signaling Initiates Choroid Plexus Tumor Formation. Oncogene 2006, 25:487-91.
  2. D Stearns, A Chaudhry, T Abel, PC. Burger, CV. Dang, CG Eberhart. c-Myc Overexpression Causes Anaplasia in Medulloblastoma. Cancer Res. 2006, 66:673-81.
  3. X Fan, W Matsui, L Khaki, D Stearns, J Chun, YM Li, CG Eberhart. Notch Pathway Inhibition Depletes Stem-like Cells and Blocks Engraftment in Embryonal Brain Tumors. Cancer Research 2006 66:7445-52.


  1. TW Abel, SJ Baker, MM Fraser, T Tihan, JS Nelson, A Yachnis, J Bouffard, H Mena, PC Burger, CG Eberhart. Lhermitte-Duclos Disease: a Report of 31 Cases with Immunohistochemical Analysis of the PTEN/AKT/mTOR Pathway. J Neuropath Exp Neurol. 2005, 64:1-9.


  1. X Fan, I Mikolaenko, I Elhassan, XZ Ni, Y Wang, D Ball, DJ Brat, A Perry, and CG. Eberhart. Notch1 and Notch2 have opposite effects on embryonal brain tumor growth. Cancer Res. 2004, 64(21):7787-93


  1. X Fan, Y Wang, J Kratz, DJ Brat, Y Robitaille, A Moghrabi, EJ Perlman, CV.  Dang, PC Burger, CG Eberhart. hTERT Gene Amplification and Increased mRNA Expression in CNS Embryonal Tumors. Am J Pathol 2003, 162(6):1763-9.


  1. JE. Kratz, D Stearns, DL Huso, HH Slunt, DL Price, DR Borchelt, CG Eberhart. Expression of stabilized beta-catenin in the CNS of adult transgenic mice does not result in tumor formation. BMC Cancer 2002, 2:33.